Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Norwest Venture Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Norwest Venture Partners

Norwest Venture Partners

Operating

Norwest: A US-based venture & growth equity firm investing in sectors like IT, SaaS, finance & healthcare.

Location
Palo Alto, CA, US
Founded
1961
Firm
Analysis
Compare
Portfolio
Employees
News
Website

Investments

Jedify
Jedify
Series A

Total Raised

$32.5M

Rounds

2

Series A$24MJune 2026
Endovascular Engineering
Endovascular Engineering

Total Raised

$137M

Rounds

3

Series C$80MApril 2026
Stablecore
Stablecore
Series A

Total Raised

$20M

Rounds

1

Series A$20MSeptember 2025
Anomalo
Anomalo

Total Raised

$72M

Rounds

4

Series B$33MJanuary 2024
Route 92 Medical
Route 92 Medical

Total Raised

$171.5M

Rounds

7

Series F$31MNovember 2023
Cytovale
Cytovale

Total Raised

$128.6M

Rounds

9

Series C$84MNovember 2023
Enable
Enable

Total Raised

$276M

Rounds

4

Series D$120MNovember 2023
Oro Labs
Oro Labs

Total Raised

$59M

Rounds

2

Series B$34MNovember 2023
Guidde
Guidde

Total Raised

$11.6M

Rounds

3

Series A$11.6MOctober 2023
Avalyn Pharma
Avalyn Pharma

Total Raised

$272.5M

Rounds

3

Series C$175MSeptember 2023
RightRev
RightRev

Total Raised

$17M

Rounds

2

Series A$12MJuly 2023
Pair Eyewear
Pair Eyewear

Total Raised

$149.5M

Rounds

7

Series C$1MJune 2023
HighFive Healthcare
HighFive Healthcare

Total Raised

$102.2M

Rounds

3

Private Equity$100MJune 2023
Vertos Medical
Vertos Medical

Total Raised

$177.8M

Rounds

14

Series C$26MJune 2023
oneNav
oneNav

Total Raised

$23.8M

Rounds

3

Series C$2.8MJune 2023
Simpplr
Simpplr

Total Raised

$131.1M

Rounds

6

Series D$70MMay 2023
Elevate CBD
Elevate CBD

Total Raised

$80.9M

Rounds

6

Series B$28MApril 2023
SlashNext
SlashNext

Total Raised

$40.5M

Rounds

3

Series BApril 2023
Numbers Station
Numbers Station

Total Raised

$17.5M

Rounds

2

Series A$12.5MMarch 2023
Clever Care Health Plan
Clever Care Health Plan

Total Raised

$139M

Rounds

5

Series C$42MMarch 2023
InfluxData
InfluxData

Total Raised

$200.9M

Rounds

7

Series E$51MFebruary 2023
Lavender
Lavender

Total Raised

$13.2M

Rounds

2

Series A$11MFebruary 2023
Setpoint Medical
Setpoint Medical

Total Raised

$344M

Rounds

12

Series Unknown$80MJanuary 2023
Amberflo
Amberflo

Total Raised

$24M

Rounds

3

Series A$15MJanuary 2023
Butter Payments
Butter Payments

Total Raised

$28.8M

Rounds

4

Series A$22MJanuary 2023